Vimab Group Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Peter Fredell
Chief executive officer
SEK 2.0m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 5.1yrs |
| CEO ownership | n/a |
| Management average tenure | 3.1yrs |
| Board average tenure | 3.1yrs |
Recent management updates
Recent updates
Take Care Before Jumping Onto Vimab Group AB (publ) (STO:VIMAB) Even Though It's 26% Cheaper
Feb 16
Vimab Group AB (publ) (STO:VIMAB) Soars 29% But It's A Story Of Risk Vs Reward
Dec 22Vimab Group AB (publ)'s (STO:VIMAB) Shares Not Telling The Full Story
Nov 06We Think Vimab Group (STO:VIMAB) Is Taking Some Risk With Its Debt
Mar 14CEO
Peter Fredell (59 yo)
5.1yrs
Tenure
SEK 2,000,000
Compensation
Mr. Peter Fredell serves as Chief Executive Officer at Vimab Group AB (publ) (formerly known as Headsent AB (publ)) since 2020 and also serves as its Director since 2022. He served as the Chief Executive O...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 5.1yrs | SEK 2.00m | no data | |
| Chief Financial Officer | 4.1yrs | no data | 0.42% SEK 820.0k | |
| Deputy CEO & COO | 3.1yrs | no data | 8.65% SEK 17.0m | |
| Sales & Technical Manager | 2.1yrs | no data | 0.0068% SEK 13.3k | |
| C. I. O | 1.1yrs | no data | 0.031% SEK 61.1k |
3.1yrs
Average Tenure
48yo
Average Age
Experienced Management: VIMAB's management team is considered experienced (3.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 3.1yrs | SEK 2.00m | no data | |
| Director | less than a year | no data | no data | |
| Independent Chairman of the Board | 3.1yrs | SEK 175.00k | no data | |
| Independent Director | 3.1yrs | SEK 100.00k | no data | |
| Employee Representative Director | less than a year | no data | no data |
3.1yrs
Average Tenure
59yo
Average Age
Experienced Board: VIMAB's board of directors are considered experienced (3.1 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/21 02:53 |
| End of Day Share Price | 2025/02/21 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Vimab Group AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.